EPIDEMIOLOGY INFORMATION RESOURCE ON OPTICAL DISC

癌症研究是全世界的一项重要活动， 许多人都参与其中;它是非常有活力的， 每年陪同。 对这项研究的信息支持至关重要 分享成果和调查结果，避免工作重复等。 该项目的目标是提供全面的癌症信息 资源（CIR），以支持全球癌症研究使用廉价的 个人电脑和光盘技术。 在成功 第一阶段的活动是开发一个全面运作的原型系统， 国际癌症研究机构（IARC） 1989/90年癌症流行病学进行中研究目录光盘- ROM（光盘-只读存储器）光盘，可在PC上操作 强大的信息检索软件。 在第二阶段，我们将 从原型到准备商业化的产品。 CIR产品将含有超过50倍体积的 信息为原型，都与癌症研究有关， 将流行病学与其他研究领域联系起来（根据 我们保留了第一期的名称， 工作，但CIR产品的内容将更广泛的范围比 原型）。 此外，该软件将大大 加强了所有数据库之间的超文本链接， 该产品将是完全集成的，并且非常容易使用。 Beta 将在第三世界国家进行测试，并在年底 在第二阶段，产品将准备用于商业分销， 全世界的癌症研究人员。

Cancer research is an important activity throughout the world in which many persons are engaged; it is extremely dynamic and much is accompanied annually. Information support for this research is critical to share results and findings, to avoid duplication of effort, etc. The goal of this project is to provide a comprehensive Cancer Information Resource (CIR) to support worldwide cancer research using inexpensive Personal Computer (PC) and optical disc technologies. In the successful Phase I activity, a fully operational prototype system was developed, which contained the International Agency for Research on Cancer (IARC) Directory of On-Going Research in Cancer Epidemiology 1989/90 on a CD- ROM (Compact Disc - Read Only Memory) optical disc, operable on a PC with powerful information retrieval software. In Phase II we will proceed from that prototype to a product ready for commercialization. The CIR product will contain more than 50 times as much volume of information as the prototype, all related to cancer research and relating epidemiology to other research areas (per the instructions of the DBIR application package, we have retained the title of the Phase I work, but the content of the CIR product will be broader in scope than that of the prototype). In addition, the software will be greatly enhanced to provide hypertext linkages among all the databases so that the product will be fully integrated and extremely easy to use. Beta testing in third-world countries will be conducted, and at the end of this Phase II the product will be ready for commercial distribution to cancer researchers throughout the world.